Log in to save to my catalogue

CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic i...

CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2930089290

CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors

About this item

Full title

CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2024-02

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

The mitotic inhibitor docetaxel (DTX) is often used to treat endocrine-refractory metastatic breast cancer, but initial responses are mitigated as patients eventually have disease progression. Using a cohort of ex vivo cultures of circulating tumor cells (CTCs) from patients with heavily pretreated breast cancer (n=18), we find two distinct pattern...

Alternative Titles

Full title

CDKN1B (p27kip1) enhances drug tolerant persister CTCs by restricting polyploidy following mitotic inhibitors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2930089290

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2930089290

Other Identifiers

E-ISSN

2692-8205

DOI

10.1101/2024.02.20.581202